Bleakley Financial Group LLC Sells 1,576 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Bleakley Financial Group LLC reduced its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 6.1% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 24,094 shares of the healthcare conglomerate’s stock after selling 1,576 shares during the quarter. Bleakley Financial Group LLC’s holdings in UnitedHealth Group were worth $12,188,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Vision Capital Management Inc. purchased a new stake in UnitedHealth Group during the 4th quarter valued at about $272,000. Meadow Creek Wealth Advisors LLC grew its stake in UnitedHealth Group by 1.9% in the 4th quarter. Meadow Creek Wealth Advisors LLC now owns 2,766 shares of the healthcare conglomerate’s stock valued at $1,399,000 after acquiring an additional 52 shares during the period. Tyche Wealth Partners LLC boosted its holdings in UnitedHealth Group by 7.3% in the 4th quarter. Tyche Wealth Partners LLC now owns 4,683 shares of the healthcare conglomerate’s stock worth $2,369,000 after buying an additional 318 shares during the last quarter. Summit Wealth Partners LLC lifted its holdings in UnitedHealth Group by 14.2% in the 4th quarter. Summit Wealth Partners LLC now owns 1,684 shares of the healthcare conglomerate’s stock valued at $852,000 after purchasing an additional 209 shares in the last quarter. Finally, Vanderbilt University increased its holdings in shares of UnitedHealth Group by 1.7% in the fourth quarter. Vanderbilt University now owns 7,867 shares of the healthcare conglomerate’s stock valued at $3,980,000 after purchasing an additional 131 shares during the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $539.50 on Thursday. The company has a market cap of $496.49 billion, a PE ratio of 34.81, a P/E/G ratio of 1.48 and a beta of 0.61. The stock has a fifty day moving average price of $533.81 and a 200 day moving average price of $564.94. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. During the same period in the prior year, the company posted $5.83 EPS. The business’s revenue for the quarter was up 6.8% on a year-over-year basis. Sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.63 EPS for the current year.

Wall Street Analyst Weigh In

UNH has been the topic of a number of analyst reports. Royal Bank of Canada reduced their target price on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 16th. Stephens increased their price objective on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research report on Thursday, December 5th. Deutsche Bank Aktiengesellschaft upped their target price on shares of UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a research report on Tuesday, December 3rd. Morgan Stanley lowered their price objective on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research report on Wednesday, October 16th. Finally, Bank of America dropped their price objective on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a research note on Wednesday, October 16th. One research analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Buy” and an average price target of $629.32.

Insiders Place Their Bets

In related news, Director Timothy Patrick Flynn acquired 1,000 shares of the company’s stock in a transaction that occurred on Friday, January 17th. The stock was purchased at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the transaction, the director now owns 4,500 shares in the company, valued at $2,302,065. This trade represents a 28.57 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 0.33% of the stock is currently owned by company insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.